Genital Warts
📧 Sign up to get email alerts when something new happens for Genital Warts.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Culturally Targeted Health Communication and Receptivity to the Human Papillomavirus Vaccine Among Parents in Flint, MI [NA]
Michigan State University-sponsored trial in Flint is evaluating culturally targeted health communication to increase parental receptivity t…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Engaging Clinical Champions to Improve HPV Vaccination [NA]
This clinical trial update reports completion of a study evaluating engaging clinical champions to improve HPV vaccination uptake.
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: HPV Vaccine Communication ECHO for Primary Care Clinics [NA]
This clinical trial update reports results from the HPV vaccine communication ECHO program for primary care clinics. The study status is com…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose [Phase 4]
Phase 4 study comparing a 3-dose Gardasil 9 schedule to a 2-dose schedule with a delayed third dose; results have been posted.
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Effectiveness Study of Human Papilloma Virus (HPV) Vaccines to Prevent Recurrence of Genital Warts [Phase 3]
A Phase 3 trial conducted by the University of Pretoria evaluated HPV vaccines for preventing recurrence of genital warts. The study has com…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: To Evaluate the Safety and Immunogenicity of 15-valent HPV Recombinant Vaccine in Chinese People Aged 9-45 Years [Phase 2]
Phase 2 clinical trial to evaluate the safety and immunogenicity of a 15-valent HPV recombinant vaccine in Chinese people aged 9-45; current…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Impact of Adolescent Vaccine Reminder Notices Sent Via Preferred Method of Communication on HPV Vaccination [NA]
This clinical trial is evaluating whether sending reminders about HPV vaccination via adolescents' preferred communication methods increases…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli) [Phase 3]
Phase 3 clinical trial evaluating a recombinant multivalent HPV vaccine (types 6,11,16,18,31,33,45,52,58) for efficacy, immunogenicity, and …
-
EMA approval · 2025-10-20EMA Authorised: Gardasil (human papillomavirus type 6 L1 protein;human papillomavirus type 11 L1 protein;human papillomavirus type 16 L1 protein;human papillomavirus type 18 L1 protein) — Merck Sharp & Dohme B.V.
The EMA authorised Gardasil, a quadrivalent human papillomavirus vaccine, for prevention of HPV infections and related diseases such as cerv…
-
EMA approval · 2025-10-09EMA Authorised: Gardasil 9 (human papillomavirus vaccine [types 6, 11, 16, 18, 31, 33, 45, 52, 58] (recombinant, adsorbed)) — Merck Sharp & Dohme B.V.
The European Medicines Agency authorised Gardasil 9, a human papillomavirus vaccine. It is indicated for preventing HPV-related conditions i…
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: Intralesional HPV Vaccine for Condylomata [Phase 1, Phase 2]
Phase 1/2 trial results for an intralesional HPV vaccine targeting genital warts (condylomata acuminata) conducted by UCSF, with results pos…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Evaluation of a Vaccine Chatbot on HPV Vaccine Confidence and Hesitancy [NA]
This clinical study evaluates a chatbot designed to improve confidence in the HPV vaccine and reduce hesitancy; the trial is not yet recruit…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Persistence of Immune Response Six Years After One Dose of 9vHPV Vaccine Among Male and Female Students [Phase 4]
Phase 4 clinical trial update showing six-year persistence of immune response after a single dose of the 9-valent HPV vaccine in male and fe…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: HPV Vaccine Reminders - SEARCH II Study [NA]
This clinical trial update summarizes the SEARCH II study on using reminders to improve uptake of the human papillomavirus vaccine; the tria…
-
CLINICAL_TRIALS research · 2025-08-20Clinical Trial Update: HPV Vaccine Reduced Dose [Phase 4]
Phase 4 trial from Emory University evaluating a reduced-dose human papillomavirus vaccine; recruitment is ongoing for HPV-related indicatio…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: Carbon Dioxide Laser vs. Electrocoagulation for the Therapy of Condyloma [NA]
This clinical trial compares carbon dioxide laser versus electrocoagulation for treating genital warts and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males [Phase 3]
Phase III trial evaluating the efficacy, immunogenicity, and safety of a recombinant HPV9-valent vaccine in Chinese males for prevention of …
-
EMA approval · 2025-07-18EMA Authorised: Aldara (imiquimod) — Viatris Healthcare Limited
The European Medicines Agency authorised Aldara (imiquimod) for multiple indications under Viatris Healthcare Limited, including genital war…
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Comparison Between Efficacy of Topical 25%Podophyllin and Cryotherapy on Genital Warts [Phase 2]
Phase 2 clinical trial comparing topical 25% podophyllin versus cryotherapy for genital warts caused by anogenital HPV infection. The study …
-
CLINICAL_TRIALS trial_result · 2025-04-08Clinical Trial Update: Long Term Follow-up of HPV Vaccine in HIV (CTN 236)
Long-term follow-up results of an HPV vaccine study in people living with HIV have been completed (CTN 236). The study investigates the vacc…
-
CLINICAL_TRIALS research · 2025-03-28Clinical Trial Update: Perception, Awareness, and Acceptance of Human Papillomavirus Disease and Vaccine Among Parents of Boys Aged 9 to 18 Years
This clinical trial update examines perception, awareness, and acceptance of HPV disease and HPV vaccination among parents of boys aged 9 to…
-
CLINICAL_TRIALS trial_result · 2025-01-13Clinical Trial Update: Efficacy, Immunogenicity, and Safety Study of the 9vHPV Vaccine in Japanese Males (V503-064) [Phase 3]
Phase 3 trial evaluating the efficacy, immunogenicity, and safety of Gardasil 9 in Japanese males has completed and results have been posted…
-
CLINICAL_TRIALS trial_result · 2025-01-06Clinical Trial Update: A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years [Phase 1]
Phase I clinical trial evaluating the safety of a 15-valent HPV vaccine in healthy Chinese adults aged 18-45. The study is currently active …
-
CLINICAL_TRIALS trial_result · 2024-12-12Clinical Trial Update: A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males [Phase 3]
Phase III trial in Chinese males evaluating the efficacy, immunogenicity and safety of the 9-valent HPV vaccine for HPV-related diseases.
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: Impact of HPV Vaccination Against Cervical Lesions and Genital Warts in Colombia. an Ecological Assessment
An ecological assessment of the impact of HPV vaccination on cervical intraepithelial neoplasia and genital warts conducted in Colombia, whi…